BMS confirms new CFO
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb has appointed Charles Bancroft chief financial officer, following the resignation of Jean-Marc Huet from the position in December. Mr Bancroft has been serving as acting CFO since the beginning of the year.